Multidrug-resistant tuberculosis in a lung transplant recipient

Journal of Heart and Lung Transplantation

Volumn 22, Issue 10, 2003, Pages 1168-1173

  Lee, Joseph ^a   Yew, Wing Wai ^a   Wong, Chi Fong ^a   Wong, Poon Chuen ^a   Chiu, Clement Shui Wah ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSERINE; CYCLOSPORIN A; ETHAMBUTOL; ETHIONAMIDE; FOSCARNET; GANCICLOVIR; ISONIAZID; LEVOFLOXACIN; OFLOXACIN; PENTAMIDINE; PREDNISOLONE; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; THYMOCYTE ANTIBODY;

ACID FAST BACTERIUM; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; CELL COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; DRUG BLOOD LEVEL; DRUG SENSITIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NEUTROPENIA; ORGAN DONOR; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; TUBERCULOSIS; VIRUS PNEUMONIA; VOMITING; X RAY ANALYSIS;

EID: 0141433264     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)01189-0     Document Type: Article

References (28)

1. Paciocco G., Martinez F.J., Kazerooni E.A., Bossone E., Lynch J.P. III. Tuberculous pneumonia complicating lung transplantation case report and review of the literature . Monaldi Arch Chest Dis. 55:2000;117-121.
2. Malouf M.A., Glanville A.R. The spectrum of mycobacterial infections after lung transplantation. Am J Respir Crit Care Med. 160:1999;1611-1616.
3. Kesten S., Chaparro C. Mycobacterial infections in lung transplant recipients. Chest. 115:1999;741-745.
4. Schulman L.L., Scully B., McGregor C.C., Austin J.H. Pulmonary tuberculosis after lung transplantation. Chest. 111:1997;1459-1462.
5. Dromer C., Nashef S.A., Velly J.F., Martigne C., Couraud L. Tuberculosis in transplanted lungs. J Heart Lung Transplant. 12:1993;924-927.
6. Roman A., Bravo C., Levy G., et al. Isoniazid prophylaxis in lung transplantation. J Heart Lung Transplant. 19:2000;903-906.
7. Lichtenstein I.H., MacGregor R.R. Mycobacterial infections in renal transplant patients report of five cases and review of the literature . Rev Infect Dis. 5:1983;216-226.
8. Korner M.M., Hirata N., Tenderich G., et al. Tuberculosis in heart transplant recipients. Chest. 111:1997;365-369.
9. Malhotra K.K., Dash S.C., Dhawan I.K., Bhuyan U.N., Gupta A. Tuberculosis and renal transplantation - observations from an endemic area of tuberculosis. Postgrad Med J. 62:1986;62-359.
10. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project . JAMA. 282:1999;677-686.
11. Espinal M.A., Laszlo A., Simonsen L., et al. Global trends in resistance to antituberculosis drugs World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance . N Engl J Med. 344:2001;1294-1303.
12. Miller R.A., Lanza L.A., Kline J.N., Geist L.J. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med. 152:1995;374-376.
13. Ridgeway A.L., Warner G.S., Philips P., et al. Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor. Am J Respir Crit Care Med. 153:1996;1166-1168.
14. Aguado J.M., Herrero J.A., Gavalda J., et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain Spanish Transplantation Infection Study Group, GESITRA . Transplantation. 63:1997;1278-1286.
15. Yew W.W. Clinically significant interactions with drugs used in the treatment of tuberculosis. Drug Saf. 25:2002;111-133.
16. Blaschke T.F., Skinner M.H. The clinical pharmacokinetics of rifabutin. Clin Infect Dis. 22:(suppl1):1996;S15.
17. Kam K.M., Yip C.W. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999; after the implementation of directly observed treatment. Int J Tuberc Lung Dis. 5:2001;815-823.
18. Di Perri G., Luzzati R., Forni A., et al. Fatal primary multidrug-resistant tuberculosis in a heart transplant recipient. Transpl Int. 11:1998;305-307.
19. Tuberculosis morbidity among U.S.-born and foreign-born populations - United States, 2000. MMWR Morb Mortal Wkly Rep. 51:2002;101-104.
20. Riley L.W., Arathoon E., Loverde V.D. The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infections a community-based study . Am Rev Respir Dis. 139:1989;1282-1285.
21. Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. WHO document 1997; WHO/TB/96.210 (Rev. 1).
22. Iseman M.D. Treatment and implications of multidrug-resistant tuberculosis for the 21st century. Chemotherapy. 45:(suppl2):1999;34.
23. Yew W.W. Therapeutic drug monitoring in anti-tuberculosis chemotherapy clinical perspectives . Clin Chim Acta. 313:2001;31-36.
24. Yew W.W., Chan C.K., Chau C.H., et al. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest. 117:2000;744-751.
25. Cheng V.C., Yuen K.Y., Chan W.M., Wong S.S., Ma E.S., Chan R.M. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis. 30:2000;882-892.
26. Narita M., Ashkin D., Hollender E.S., Pitchenik A.E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 158:1998;157-161.
27. Mazurek G.H., LoBue P.A., Daley C.L., et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Myocobacterium tuberculosis infection. JAMA. 286:2001;1740-1747.
28. Blockstahler L.E., Li Z., Nguyen N.Y., et al. Peptide nucleic acid probe detection of mutations in Myobacterium tuberculosis genes associated with drug resistance. Biotechniques. 32:2002;508-510. 512, 514.